199 related articles for article (PubMed ID: 35442058)
1. Bone turnover markers as surrogates of fracture healing after intramedullary fixation of tibia and femur fractures.
Stewart CC; O'Hara NN; Bzovsky S; Bahney CS; Sprague S; Slobogean GP;
Bone Joint Res; 2022 Apr; 11(4):239-250. PubMed ID: 35442058
[TBL] [Abstract][Full Text] [Related]
2. Serum 25(OH)D is associated with an altered bone turnover marker response after a hip fracture.
Stewart CC; O'Hara NN; Orwig D; Hochberg MC; Sprague S; Magaziner J; Slobogean GP
J Orthop Res; 2019 Mar; 37(3):535-540. PubMed ID: 30578572
[TBL] [Abstract][Full Text] [Related]
3. Changes of bone turnover markers after elderly hip fracture surgery.
Li XP; Li XY; Yang MH; Zhu SW; Wu XB; Zhang P
J Bone Miner Metab; 2021 Mar; 39(2):237-244. PubMed ID: 32876727
[TBL] [Abstract][Full Text] [Related]
4. Prognostic potential of markers of bone turnover in delayed-healing tibial diaphyseal fractures.
Kumar M; Shelke D; Shah S
Eur J Trauma Emerg Surg; 2019 Feb; 45(1):31-38. PubMed ID: 29149352
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin D
Madar AA; Knutsen KV; Stene LC; Brekke M; Lagerløv P; Meyer HE; Macdonald HM
Bone Rep; 2015 Jun; 2():82-88. PubMed ID: 28377958
[TBL] [Abstract][Full Text] [Related]
6. Assessment of baseline bone turnover marker levels and response to risedronate treatment: Data from a Japanese phase III trial.
Mawatari T; Ikemura S; Matsui G; Iguchi T; Mitsuyasu H; Kawahara S; Maehara M; Muraoka R; Iwamoto Y; Nakashima Y
Bone Rep; 2020 Jun; 12():100275. PubMed ID: 32462056
[TBL] [Abstract][Full Text] [Related]
7. Target Values and Daytime Variation of Bone Turnover Markers in Monitoring Osteoporosis Treatment After Fractures.
Borgen TT; Solberg LB; Lauritzen T; Apalset EM; Bjørnerem Å; Eriksen EF
JBMR Plus; 2022 Jun; 6(6):e10633. PubMed ID: 35720666
[TBL] [Abstract][Full Text] [Related]
8. Changes in bone mass and bone turnover following tibial shaft fracture.
Veitch SW; Findlay SC; Hamer AJ; Blumsohn A; Eastell R; Ingle BM
Osteoporos Int; 2006; 17(3):364-72. PubMed ID: 16362144
[TBL] [Abstract][Full Text] [Related]
9. Elevated Bone Turnover Markers Are Associated With Distal Radius Fractures in Premenopausal Women.
Ting BL; Walley KC; Travison TG; Rozental TD
J Hand Surg Am; 2017 Feb; 42(2):71-77. PubMed ID: 28160903
[TBL] [Abstract][Full Text] [Related]
10. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
[TBL] [Abstract][Full Text] [Related]
11. Bone Turnover Markers Do Not Predict Fracture Risk in Type 2 Diabetes.
Napoli N; Conte C; Eastell R; Ewing SK; Bauer DC; Strotmeyer ES; Black DM; Samelson EJ; Vittinghoff E; Schwartz AV
J Bone Miner Res; 2020 Dec; 35(12):2363-2371. PubMed ID: 32717111
[TBL] [Abstract][Full Text] [Related]
12. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
13. Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.
Nahas-Neto J; Cangussu LM; Orsatti CL; Bueloni-Dias FN; Poloni PF; Schmitt EB; Nahas EAP
Osteoporos Int; 2018 May; 29(5):1125-1133. PubMed ID: 29450585
[TBL] [Abstract][Full Text] [Related]
14. Bone turnover marker determinants in young women: results from the Safe-D study.
Callegari ET; Garland SM; Gorelik A; Chiang CY; Wark JD
Ann Clin Biochem; 2018 May; 55(3):328-340. PubMed ID: 28656813
[TBL] [Abstract][Full Text] [Related]
15. Effects of Vitamin D Supplementation on Bone Turnover Markers: A Randomized Controlled Trial.
Schwetz V; Trummer C; Pandis M; Grübler MR; Verheyen N; Gaksch M; Zittermann A; März W; Aberer F; Lang A; Treiber G; Friedl C; Obermayer-Pietsch B; Pieber TR; Tomaschitz A; Pilz S
Nutrients; 2017 Apr; 9(5):. PubMed ID: 28448457
[TBL] [Abstract][Full Text] [Related]
16. Serum 25-hydroxyvitamin D, bone turnover markers and bone mineral density in postmenopausal women with hip fractures.
Fan J; Li N; Gong X; He L
Clin Chim Acta; 2018 Feb; 477():135-140. PubMed ID: 29246667
[TBL] [Abstract][Full Text] [Related]
17. 25-Hydroxyvitamin-D and Bone Turnover Marker Levels in Patients with Distal Radial Fracture.
Rozental TD; Herder LM; Walley KC; Zurakowski D; Coyle K; Bouxsein ML; Wolf JM
J Bone Joint Surg Am; 2015 Oct; 97(20):1685-93. PubMed ID: 26491133
[TBL] [Abstract][Full Text] [Related]
18. Calciotropic Hormones and the Prevalence of Vertebral Fractures in Chinese Postmenopausal Women with Vitamin D Insufficiency: Peking Vertebral Fracture Study.
Jiajue R; Jiang Y; Qi X; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
Calcif Tissue Int; 2019 Jun; 104(6):622-630. PubMed ID: 30737534
[TBL] [Abstract][Full Text] [Related]
19. The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial.
Hadji P; Stoetzer O; Decker T; Kurbacher CM; Marmé F; Schneeweiss A; Mundhenke C; Distelrath A; Fasching PA; Lux MP; Lüftner D; Janni W; Muth M; Kreuzeder J; Quiering C; Grischke EM; Tesch H
J Bone Oncol; 2019 Feb; 14():010-10. PubMed ID: 30515367
[TBL] [Abstract][Full Text] [Related]
20. Novel serological biomarker models composed of bone turnover markers, vitamin D, and estradiol and their auxiliary diagnostic value in girls with idiopathic central precocious puberty.
Zhang J; Gao R; Jiang Y; Zhang Y; Liu C; Yu F; Zhou W
Bone; 2022 Jan; 154():116221. PubMed ID: 34600161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]